5 Best Dow Stocks to Invest In Now
Summary
On April 20, Guggenheim Partners raised its price recommendation on Johnson & Johnson (NYSE:JNJ) to $266 from $244. It reiterated a Buy rating on the shares.
Description
On April 20, Guggenheim Partners raised its price recommendation on Johnson & Johnson (NYSE:JNJ) to $266 from $244. It reiterated a Buy rating on the shares.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source